US equities
|
MU
$1,088.00
▲+4.06%
NVDA
$237.47
▼-0.74%
SNDK
$1,692.42
▲+1.92%
SPCX
$167.60
▼-2.51%
AMD
$645.86
▼-0.55%
AAPL
$336.67
▲+0.91%
TSLA
$377.81
▼-0.75%
META
$721.31
▼-2.38%
MU
$1,088.00
▲+4.06%
NVDA
$237.47
▼-0.74%
SNDK
$1,692.42
▲+1.92%
SPCX
$167.60
▼-2.51%
AMD
$645.86
▼-0.55%
AAPL
$336.67
▲+0.91%
TSLA
$377.81
▼-0.75%
META
$721.31
▼-2.38%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Medisca
Medisca and EUROAPI Form Strategic Partnership to Strengthen API Access for Pharmaceutical Compounding
October 07, 2026
From
Medisca
Via
Business Wire
Medisca Launches Global Peptide Division
September 17, 2026
From
Medisca
Via
Business Wire
Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos
June 29, 2026
From
Medisca
Via
Business Wire
Medisca and dsm–firmenich Partner to Expand Access to Pharmaceutical-Grade Vitamin APIs for U.S. Compounding Market
May 12, 2026
From
Medisca
Via
Business Wire
Medisca Secures Settlement With FlackTek, Reinforcing Patent Strength of MAZ® Mixer
June 10, 2025
From
Medisca
Via
Business Wire
Medisca Opens New Pharmaceutical Repackaging Facility to Meet Global Demands in Personalized Medicine
June 27, 2024
From
Medisca
Via
Business Wire
A new chapter for Medisca: Sanjay D. Goorachurn appointed as Chief Executive Officer
April 16, 2024
From
Medisca
Via
Business Wire
Medisca Opens MAZ® Lab in Arizona: An Innovation and Customer Resource Center
March 26, 2024
From
Medisca
Via
Business Wire
Medisca Takes Additional Steps to Protect Its Innovative Technologies
October 13, 2023
From
Medisca
Via
Business Wire
Medisca Takes Steps to Protect its Innovative Technologies
September 26, 2023
From
Medisca
Via
Business Wire
Medisca Expands Strategic Partnerships to Drive Patient Access to Critical Medications
July 27, 2023
From
Medisca
Via
Business Wire
Medisca to Open New Plattsburgh, NY Facility Exceeding Rigorous Quality and Employee Safety Standards
October 27, 2022
From
Medisca
Via
Business Wire
Medisca Unveils New Brand Identity and Corporate Positioning as Partners in Wellness
August 22, 2022
From
Medisca
Via
Business Wire
Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA
May 26, 2022
From
Medisca
Via
Business Wire
Medisca Pledges Another $100,000 in Matching Donations to the Alliance for Pharmacy Compounding Media Campaign Fund to Secure Compounded Hormone Therapy
March 25, 2022
From
Medisca
Via
Business Wire
Medisca Signs Deal as Exclusive Global Distributor outside the USA & Israel for the Padagis Line of ORA Products
January 12, 2022
From
Medisca
Via
Business Wire
MEDISCA Launches New Thyroid API - Now Available to Compounding Pharmacists After Years of Industry-Wide Disruptions to Supply
August 26, 2021
From
MEDISCA
Via
Business Wire
MEDISCA $100,000 Pledge to Protect Compounded Hormone Therapy Encourages Industry-wide Response - Doubling Donations in 1 Month.
July 09, 2021
From
MEDISCA
Via
Business Wire
MEDISCA Strategic Partnership Stabilizes Industry Supply of Thyroid API
June 01, 2021
From
MEDISCA
Via
Business Wire
MEDISCA Pledges $100,000 to Alliance for Pharmacy Compounding (APC) National Media Campaign to Help Protect Compounded Hormone Therapy Medications.
April 09, 2021
From
MEDISCA
Via
Business Wire
